Does metabolic syndrome influence short and long term durability of carotid endarterectomy and stenting?
<br/><strong>Aims: </strong>The metabolic syndrome (MetS) is composed of a cluster of related cardiovascular risk factors. The aim of the present study was to determine how MetS contributes to short‐ (30‐day) and long‐term complications and restenosis after carotid endarterectomy (...
主要な著者: | Casana, R, Malloggi, C, Tolva, V, Odero, A, Bulbulia, R, Halliday, A, Silani, V |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Wiley
2018
|
類似資料
-
Is diabetes a marker of higher risk after carotid revascularization? Experience from a single centre
著者:: Casana, R, 等
出版事項: (2018) -
Antiplatelet therapy in carotid artery stenting and carotid endarterectomy in the asymptomatic carotid surgery trial-2
著者:: Huibers, A, 等
出版事項: (2015) -
Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting.
著者:: Giannoukas, A, 等
出版事項: (2014) -
The Asymptomatic Carotid Surgery Trial-2 (ACST-2): An ongoing randomised trial comparing carotid endarterectomy with carotid artery stenting to prevent stroke
著者:: Bulbulia, R, 等
出版事項: (2017) -
Meta-analysis of the procedural risks of carotid endarterectomy and carotid artery stenting over time
著者:: Lokuge, K, 等
出版事項: (2017)